Model DetailsLung tumor
Model Name |
Lung tumor | Strain |
BALB/c |
Tumor Inducing Agent(s) |
Hormone, Chemical/Drug, Other : mainstream cigarette smoke (MCS) |
Tumor Synonym |
lung tumor |
Strain Synonyms |
Bagg • B alb C • C • Bagg Albino • BALB • Bagg albino • balb/c • C strain • WT • BALB/c (WT) • BALB/C • Cb |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Lung | Unspecified |
high |
|
Festing MFW, Mouse Genome 1996;94(3):523-677 | |
| Lung | Unspecified |
high |
31 weeks after treatment |
|
Shimkin MB, J Natl Cancer Inst 1966;36():915-35 |
| Lung | Unspecified |
very high |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 | |
| Lung | Unspecified |
85% (17 of 20 mice) |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 | |
| Lung | Unspecified |
53% (9 of 17 mice) |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 | |
| Lung | Unspecified |
very high |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 | |
| Lung | Unspecified |
very high |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 | |
| Lung | Unspecified |
100% (38 of 38 mice) |
43-59 weeks |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Unspecified |
19% (4 of 21 mice) |
43-59 weeks |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Unspecified |
35% (14 of 40 mice) |
43-59 weeks |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Unspecified |
53% (16 of 30 mice) |
43-59 weeks |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Unspecified |
90% (36 of 40 mice) |
43-59 weeks |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Unspecified |
95% (19 of 20 mice) |
43-59 weeks |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Unspecified |
95% (38 of 40 mice) |
43-59 weeks |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Unspecified |
100% (22 of 22 mice) |
43-59 weeks |
|
Shimkin MB, Adv Cancer Res 1975;21():1-58 |
| Lung | Female |
21.05% (4 of 19 mice) |
|
Gordon T, Cancer Lett 2009 Mar 18;275(2):213-20 | |
| Lung | Female |
observed |
|
Gordon T, Cancer Lett 2009 Mar 18;275(2):213-20 |